# Sera Prognostics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sera-prognostics

- Industry: Medical Devices & Equipment
- Headquarters: Salt Lake City, US
- Website: www.seraprognostics.com
- Total disclosed funding: $178M
- Latest round: Series E (Feb 23, 2021)
- Investors on record: 14

## About

Based in Utah, US, Sera Prognostics, Inc. was founded in 2008 by co-founders Dennis Farrar, Sean Esplin, and Steven Graves. Dr. Critchfield became the CEO of the company in November 2011. As of 2021, Sera Prognostics has 74 employees. In February 2021, Sera Prognostics raised USD 100.3 million in series E funding, and in July 2021, Sera Prognostics, Inc. raised USD 75 million in an IPO, selling 4.69 million shares at USD 16 per share on the NASDAQ. 

Sera Prognostics, Inc. provides the PreTRM® Test, a pregnancy testing kit that predicts early preterm birth risk of pregnancy complications and helps pregnant women and doctors to understand the potential pregnancy risk. The firm's platform uses proprietary biomarkers that are predictive of preterm birth, preeclampsia, and other pregnancy complications.

Sera Prognostics, Inc. plans to use its Series E funding in April 2021 to continue commercializing its PreTRM® testing, accelerate the development of its pipeline of biomarker tests to predict other major conditions of pregnancy, and develop greater testing capacity.

## Funding rounds

- Series E, Feb 23, 2021, $62M — Vivo Capital, Elevance Health, Inc., Blue Ox Healthcare Partners, aMoon, Parian Global Management
- Series D, Jul 31, 2019, $26M — Domain Associates, InterWest Partners, Catalyst Health Ventures, Laboratory Corporation of America Holdings, Chione, Blue Ox Healthcare Partners
- Series C, Jan 10, 2017, $40M — Domain Associates, InterWest Partners, Catalyst Health Ventures, Laboratory Corporation of America Holdings, Bill and Melinda Gates Foundation
- Series B, Jan 7, 2015, $25M — Domain Associates, InterWest Partners, OUP (Osage University Partners), Catalyst Health Ventures, UpStart Ventures, Bill & Melinda Gates Foundation, Chione
- Series B, Nov 18, 2014, $5M — Domain Associates, Catalyst Health Ventures, UpStart Ventures, Chione
- Series A, Nov 15, 2011, $19M — Domain Associates, InterWest Partners, OUP (Osage University Partners), Catalyst Health Ventures, UpStart Ventures
- Series A, Jan 4, 2011, $1.4M — Catalyst Health Ventures, UpStart Ventures

## Investors

- Catalyst Health Ventures (https://capitalatlas.ai/funds/catalyst-health-ventures) — Series A, Series B, Series C, Series D
- UpStart Ventures — Series A, Series B
- Domain Associates (https://capitalatlas.ai/funds/domain-associates) — Series A, Series B, Series C, Series D
- InterWest Partners (https://capitalatlas.ai/funds/interwest-partners) — Series A, Series B, Series C, Series D
- OUP (Osage University Partners) (https://capitalatlas.ai/funds/oup-osage-university-partners) — Series A, Series B
- Chione — Series B, Series D
- Bill & Melinda Gates Foundation — Series B
- Laboratory Corporation of America Holdings — Series C, Series D
- Bill and Melinda Gates Foundation — Series C
- Blue Ox Healthcare Partners (https://capitalatlas.ai/funds/blue-ox-healthcare-partners) — Series D, Series E
- Vivo Capital (https://capitalatlas.ai/funds/vivo-capital) — Series E
- Elevance Health, Inc. — Series E
- aMoon (https://capitalatlas.ai/funds/amoon) — Series E
- Parian Global Management (https://capitalatlas.ai/funds/parian-global-management) — Series E